Perrigo Company plc (BVMF:P1RG34)

Market Cap	10.19B
Revenue (ttm)	22.87B
Net Income (ttm)	-276.73M
Shares Out	n/a
EPS (ttm)	-2.00
PE Ratio	n/a
Forward PE	4.76
Dividend	4.63 (6.23%)
Ex-Dividend Date	Nov 27, 2025

Volume	2
Average Volume	192
Open	74.13
Previous Close	74.27
Day's Range	74.13 - 74.27
52-Week Range	66.36 - 151.56
Beta	0.36
RSI	32.06
Earnings Date	Nov 5, 2025

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,379
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: P1RG34

Financial Performance

In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.

Financial numbers in USD